Conference Coverage

Bismuth subgallate cuts stool smell after duodenal switch


 

REPORTING FROM SAGES 2018

– Bismuth subgallate (Devrom) is a big help with an embarrassing and underappreciated problem after loop duodenal switch: smelly flatulence and stool.

Bismuth subgallate, an over the counter product that’s been on the market for decades, has been primarily studied to eliminate the odor of flatulence and bowel movements in ostomates, according to Walter Medlin, MD, a surgeon at the Bariatric Medicine Institute in Salt Lake City.

Dr. Walter Medlin, a surgeon at the Bariatric Medicine Institute in South Salt Lake City

Dr. Walter Medlin

Loop duodenal switch (LDS) generally causes fat and starch malabsorption, which is good for weight loss but can result in odor problems that can “give rise to social and family conflicts” and be disabling.

“A lot of patients have this complaint, but they tend not to talk to their physicians about it,” Dr. Medlin said at the World Congress of Endoscopic Surgery hosted by SAGES & CAGS.

Enter bismuth subgallate. Dr. Medlin and his team randomized 36 LDS patients to 200-mg capsules, two per meal, or to placebo for a week. Patients then underwent a one-week washout period, then crossed over to bismuth subgallate or placebo for another week. Patients and surgeons were blinded to treatment groups.

Subjects were at least 6 months out from LDS to give their gut a chance to adapt to the surgery. Patients with GI infections and those on confounding medications were among those excluded from the study. The mean age of the patients was 48 years, and there were slightly more women than men.

Subjects filled out the Gastrointestinal Quality of Life Index questionnaire at baseline and after both treatment periods. The index assesses digestive symptoms, physical status, emotional status, social performance, and treatment effects. Additional measures were added: Patients rated stool smell, flatulence smell, and concerns about each on a 4-point scale.

Pages

Recommended Reading

Patients with CF at increased risk for GI cancers
MDedge Internal Medicine
Advanced adenoma on colonoscopy linked to increased colorectal cancer incidence
MDedge Internal Medicine
ESBL-B before colorectal surgery ups risk of surgical site infection
MDedge Internal Medicine
Breath test may detect esophagogastric cancer
MDedge Internal Medicine
How to choose between highly effective HBV therapies
MDedge Internal Medicine
VIDEO: Characteristic flora define intestinal microbiome in scleroderma
MDedge Internal Medicine
Blood type A linked to more-severe diarrhea
MDedge Internal Medicine
IBD upped Parkinson’s risk in large study
MDedge Internal Medicine
FDA approves Doptelet for liver disease patients undergoing procedures
MDedge Internal Medicine
Recent studies of microbiota offer insights into digestive disease management
MDedge Internal Medicine